The stock has become the S&P 500’s top performer ... less severe-than-expected medical trends supported the performance. For 2025, CVS Health projects $132 billion in healthcare benefits ...

CVS Health (CVS) closed the most recent trading day at $68.54, moving -0.55% from the previous trading session. This move was narrower than the S&P 500's daily loss of 2.24%. Meanwhile, the Dow ...

CVS Health is clearly the pharmacy everyone wants in their investment cart, with Envestnet Asset Management bumping up its ...

CVS Health (NYSE: CVS) has defied the odds and is up over 50% year-to-date, whereas the broader market has corrected ...

CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.

CNBC’s Jim Cramer on Tuesday suggested why CVS and Dollar General have seen gains recently after lagging last year.

CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now? Let's take a closer look. Major stock market indexes are down ...

Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

These leadership updates, coupled with a favorable financial outlook, have positioned CVS positively, despite a backdrop of market volatility linked to recent tariff uncertainties impacting global ...

The most recent guidance for CVS Health (CVS) was reported on April 8, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $5.75 to $6.00, compared to the ...